Detalhe da pesquisa
1.
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.
Ann Rheum Dis
; 82(12): 1587-1593, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734881
2.
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
Respir Res
; 24(1): 135, 2023 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210543
3.
Basal Tryptase High Levels Associated with a History of Arterial Hypertension and Hypercholesterolemia Represent Risk Factors for Severe Anaphylaxis in Hymenoptera Venom-Allergic Subjects over 50 Years Old.
Int Arch Allergy Immunol
; 182(2): 146-152, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33264768
4.
Role of Multiple Comorbidities and Therapies in Conditioning the Clinical Severity of DRESS: A Mono-Center Retrospective Study of 25 Cases.
Int J Mol Sci
; 22(13)2021 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209467
5.
Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients.
Int Arch Allergy Immunol
; 180(1): 64-71, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189169
6.
Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature.
Clin Mol Allergy
; 15: 16, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29026345
7.
Serum tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular events after 2 years.
Clin Mol Allergy
; 13(1): 14, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26038676
8.
Serum tryptase: a new biomarker in patients with acute coronary syndrome?
Int Arch Allergy Immunol
; 164(2): 97-105, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24943670
9.
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study.
J Asthma Allergy
; 17: 273-290, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562251
10.
Unraveling the complexities of drug reaction with eosinophilia and systemic symptoms (DRESS): Insights into clinical, laboratory, and histopathologic features of a case series from an Italian tertiary center.
Clin Dermatol
; 41(6): 721-728, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37730074
11.
Evolution in Endoscopic Sinus Surgery: The Adjuvant Role of Reboot Surgery in Patients with Uncontrolled Nasal Symptoms of Eosinophilic Granulomatosis with Polyangiitis.
J Pers Med
; 13(4)2023 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37109033
12.
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.
Lancet Rheumatol
; 5(12): e707-e715, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38251561
13.
Airborne anaphylaxis: highlighting an invisible enemy.
Curr Opin Allergy Clin Immunol
; 22(5): 283-290, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942858
14.
A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2.
Clin Dermatol
; 40(5): 591-594, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550918
15.
Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study.
J Asthma Allergy
; 15: 1593-1604, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36387835
16.
Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years' Follow-Up: A Case Report.
Case Rep Dermatol
; 12(3): 174-177, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173477